Over the past 12 months, 0 insiders at PhaseBio Pharmaceuticals Inc filed 0 open-market SEC Form 4 transactions on PHAS: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 25, 22 | New Enterprise Associates 13 LpTenPercentOwner | SELL | 1.78M | $0.15 | $268K |
| May 23, 22 | Glen BurkhardtSVP of Human Resources | SELL | 11.2K | $0.79 | $9K |
| Nov 19, 21 | Glen BurkhardtVP, Human Resources | SELL | 5.8K | $2.37 | $14K |
| Aug 18, 21 | Nancy J HutsonDirector | BUY | 3.0K | $3.08 | $9K |
| Aug 18, 21 | Clay ThorpDirector | BUY | 10.0K | $3.00 | $30K |
Over the past 12 months, insiders at PhaseBio Pharmaceuticals Inc filed 0 open-market purchases worth $0 and 0 sales worth $0 on PHAS, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market PHAS insider purchase in our data was $30K by Clay Thorp, Director, filed on Aug 18, 21.
0 different insiders at PhaseBio Pharmaceuticals Inc filed open-market SEC Form 4 transactions on PHAS over the last 12 months.
InsiderTape plots every PHAS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every PhaseBio Pharmaceuticals Inc insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →